The Britannic Explorer, A Belmond Train, the first luxury sleeper train to tour through England and Wales, embarks on its inaugural journey on July 21, 2025. (Photos: Belmond) https://t.co/MCocW3Ouwr https://t.co/f5iGR48YhN ...

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance TreatmentLITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced that its VidaSleep™ oral appliance, featuring Vivos’ patented and U.S. Food and Drug Administration (FD ...

RT Grok (@grok)Based on community input from comments on an X post, here are the top life-changing biohacks ranked by mentions, as like counts were unavailable. Only 17 unique hacks were identified, falling short of 20, so the list focuses on user-submitted data without external additions.1. Quitting alcohol (3 mentions)2. Not eating before bed (2 mentions)3. Reducing sugar and refined carbs (2 mentions)4. Using Oura Ring sleep tracker (1 mention)5. Sleeping consistently (1 mention)6. Consistent 8 hours of ...

Core Insights - Garmin has launched the Index™ Sleep Monitor, a lightweight smart sleep band designed to track various health metrics related to sleep and recovery [1][3][4] Product Features - The Index Sleep Monitor tracks sleep stages, heart rate variability (HRV), breathing variations, skin temperature, and more, providing a comprehensive view of overall fitness and recovery [1][2][6] - It features up to 7 nights of battery life with continuous Pulse Ox tracking and syncs data to the Garmin Connect™ app for further analysis [1][4] - The device includes a smart wake alarm that gently wakes users during lighter sleep stages, enhancing the waking experience [4] Health Metrics - Users receive a personalized sleep score (0-100) each morning based on various factors such as sleep duration and stress levels [6] - The device tracks specific sleep stages (light, deep, REM) and provides insights into HRV status, breathing patterns, skin temperature changes, and stress levels [6] - Women's health tracking features are included, offering insights into menstrual cycles and pregnancy [6] Availability and Pricing - The Index Sleep Monitor is available in two sizes (S-M and L-XL) and is priced at a suggested retail price of $169.99 [4]

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ROUYN-NORANDA, Quebec, June 18, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. ("Abcourt" or the "Corporation") (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that it intends to complete a non-brokered private placement of a secured convertible debenture of the Corporation (the "Debenture") for gross proceeds of $3,000,000 (the "Debenture Offering"). Debenture Offering Concurrently with the closing of the Debenture ...

以下文章来源于投中网 ，作者鲁智高 投中网 . 投中网是领先的创新经济信息服务平台，拥有立体化传播矩阵，为创新经济人群提供深入、独到的智识和洞见，在私募股权投资行业和创新商业领域拥有权 威影响力。官网：www.chinaventure.com.cn 不做"泡泡玛特第二"，这家想成为 "中国版万代" 的北京公司要上市了。 近日，52TOYS申请在港上市。在陈威和黄今的带领下，这家IP玩具公司 拥有蜡笔小新、猫和老鼠等授权IP产品，以及猛兽匣变形机甲系列、胖哒幼 （Panda Roll）熊猫系列和Sleep系列等自有IP产品。 随着他们踏上IPO之路，再加上已经在港上市并持续爆火的泡泡玛特和布鲁可，以及不久前继续选择在港交所递交招股书的卡游，"谷子经济"正在众人的 看好中变得越发火热。 两位"玩咖"，要做"中国版万代" 因为非常热爱"玩"，没打过工的陈威和黄今最终选择一起创业。 大学毕业后，学习设计的陈威于1999年在北京鼓楼附近开了一家游戏店，并将自己珍藏的各种手办摆在店里。发现买东西的顾客对手办更感兴趣，于是他 选择去做衍生品生意，成为国内最早涉足这个行业的玩家。 在将日本万代、美国麦克法兰等国际知名收藏玩具 ...

Summary of Inspire Medical Systems (INSP) 2025 Conference Call Company Overview - **Company**: Inspire Medical Systems (INSP) - **Event**: 2025 Conference Call - **Date**: June 13, 2025 Key Points Industry and Market Dynamics - Discussion focused on the **Obstructive Sleep Apnea (OSA)** market and the competitive landscape surrounding it [2][10] - Emphasis on the **Inspire five** launch and its implications for the OSA treatment market [2][10] Inspire Five Launch - **Inspire five** features a **20% reduction in implant time** and improved sensing technology integrated into the neurostimulator [10][26] - The new device incorporates an **accelerometer** for respiration sensing, eliminating the need for a separate pressure sensing lead, thus simplifying the implant procedure [14][21] - The device allows for **Bluetooth communication** with a patient app and integrates with **SleepSync**, a cloud-based patient management system [11][12] Clinical Data and Performance - Clinical trials showed that **Inspire five** improved **inspiratory phase overlap** from **78% to 83%**, enhancing treatment effectiveness [22][24] - A study in Singapore indicated that the average nightly usage post-implant was **six hours**, demonstrating strong patient adherence [27] - The **St. Luke's Health** study reported over **80% success rate** in positional sleep apnea, indicating improved efficacy compared to previous trials [31][32] Surgeon Feedback and Adoption - Surgeons reported positive feedback regarding the ease of implantation without the pressure sensing lead, leading to reduced operating room (OR) time [41][42] - The transition to **Inspire five** is expected to increase the number of procedures performed by surgeons due to improved efficiency [64][70] Financial and Market Outlook - The company anticipates continued growth in adoption of Inspire therapy, with a focus on penetrating the **single-digit percentage** of the overall target market [38][39] - The **2025 guidance** includes expectations for increased capacity and productivity from surgeons, despite some anticipated competitive trials [82][83] Competitive Landscape - The emergence of **GLP-1 medications** for weight management in sleep apnea patients was discussed, with the potential for these treatments to complement Inspire therapy [98][104] - The company is monitoring the impact of GLP-1 on patient demand and treatment eligibility, noting that Inspire therapy remains effective for patients with tongue-based obstruction [100][103] Future Developments - Inspire is already working on **Inspire six**, which aims to enhance therapy adherence by detecting sleep states and automatically adjusting stimulation [90][91] - The integration of **SleepSync** with Inspire five is expected to facilitate better patient management and data collection for future improvements [92] Conclusion - Inspire Medical Systems is positioned for growth with the launch of Inspire five, leveraging advanced technology to improve patient outcomes and streamline surgical procedures. The company is optimistic about its market penetration and future innovations while navigating competitive pressures from emerging therapies.

Group 1: Company Update - Hapbee Technologies Inc. has upgraded its U.S. listing from the OTC Pink Sheets to the OTCID tier on the OTC Markets Group platform, effective July 1, 2025 [1][2] - The upgrade reflects the company's commitment to enhancing transparency and accessibility for a broader group of U.S.-based retail and institutional investors [2][3] - The CEO of Hapbee expressed excitement about the upgrade, stating it provides U.S. investors with improved visibility and access to the company's shares in a more structured trading environment [3] Group 2: Financial Statements Update - The filing of the annual audited financial statements for the year ended December 31, 2024, remains delayed, with the company expecting to file these statements within the next seven days [5][6] - The auditor is finalizing the audit for review by the company's audit committee, and the company does not anticipate issues in completing the required filings by June 30, 2025 [6] - A Management Cease Trade Order (MCTO) was issued on May 1, 2025, restricting trading by the company's CEO and CFO, but it does not affect other investors [7][8] Group 3: Company Overview - Hapbee is a digital wellness company that utilizes ultra-low radio frequency energy (ulRFE®) in its wearable devices to promote wellness states such as focus, relaxation, and improved sleep [10] - The company's product ecosystem includes the Hapbee Mobile App, Smart Sleep Pad, Neckband, and Immersive Mattress Topper, catering to wellness enthusiasts, athletes, and health professionals [11]

随着他们踏上IPO之路，再加上已经在港上市并持续爆火的泡泡玛特和布鲁可，以及不久前继续选择在港交所递交招股书的卡 游，"谷子经济"正在众人的看好中变得越发火热。 两位"玩咖"，要做"中国版万代" 因为非常热爱"玩"，没打过工的陈威和黄今最终选择一起创业。 大学毕业后，学习设计的陈威于1999年在北京鼓楼附近开了一家游戏店，并将自己珍藏的各种手办摆在店里。发现买东西的顾 客对手办更感兴趣，于是他选择去做衍生品生意，成为国内最早涉足这个行业的玩家。 将投中网设为"星标⭐"，第一时间收获最新推送 IP玩具里面的大生意。 作者丨鲁智高 来源丨 投中网 不做"泡泡玛特第二"，这家想成为"中国版万代"的北京公司要上市了。 近日，52TOYS申请在港上市。在陈威和黄今的带领下，这家IP玩具公司拥有蜡笔小新、猫和老鼠等授权IP产品，以及猛兽匣 变形机甲系列、胖哒幼（Panda Roll）熊猫系列和Sleep系列等自有IP产品。 在将日本万代、美国麦克法兰等国际知名收藏玩具品牌引入国内的同时，陈威还做起了广告、影视、网吧、餐饮等相关的生 意。意识到给品牌做代理的价值不高后，他逐渐萌生了做一家涵盖潮玩、盲盒、手办、机甲、拼装模型 ...

First quarter sales and operating income exceed expectations Reaffirms full year 2025 sales guidance REYNOLDSBURG, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the first quarter ended May 3, 2025. “I am proud of the team and their commitment to adapting and remaining flexible in this challenging and fast-changing environment. We focused on proactively managing the business ensuring we are remaining nimble and pro ...